Catherine Stedman | |
---|---|
Academic background | |
Alma mater | University of Sydney |
Thesis |
|
Academic work | |
Discipline |
|
Institutions | University of Otago |
Website | University of Otago profile |
Catherine Ann Malcolm Stedman is a New Zealand pharmacologist and gastroenterologist, and is a clinical professor at the University of Otago, specialising in hepatitis C drug development. She is the first woman gastroenterologist to become a professor of medicine in New Zealand.
Stedman completed her undergraduate medical degree at the University of Otago, and then undertook a PhD titled Role of nuclear receptors in bile acid disposition and detoxification at the University of Sydney in 2006. [1] Her clinical training in pharmacology and gastroenterology took place at Christchurch Hospital and Westmead Hospital in Sydney. [2] Stedman then worked in the Salk Institute, and on drug safety for a pharmaceutical company. [2] Stedman returned to Christchurch Hospital as a consultant gastroenterologist and joined the faculty of the University of Otago, rising to clinical associate professor in 2015 and full professor in 2023. [3] [4] She is the first woman gastroenterologist to become a professor of medicine in New Zealand. [2]
Stedman's research focuses on drug development for hepatitis C treatment, although she is also interested in autoimmune liver diseases, and how they affect the lives and life expectancy of people who have them. Stedman has been a principal investigator in a large number of clinical trials aimed at testing antiviral therapies, and led the first successful clinical trial in the world to show that oral antiviral treatment could cure hepatitis C. [4] Stedman has also led trials for antiviral therapies aimed at patients with liver failure resulting from hepatitis C. [4] As a result of these trials, and other potential therapies, the World Health Organization has proposed elimination of hepatitis C. [4] [5] [6] [7]
As of 2024, Stedman is the president of the New Zealand Society of Gastroenterology. [2]
In 2019 Stedman was awarded the Gold Research Medal by the University of Otago Christchurch campus. [8]
{{
cite journal}}
: CS1 maint: numeric names: authors list (
link){{
cite journal}}
: CS1 maint: numeric names: authors list (
link)
Catherine Stedman | |
---|---|
Academic background | |
Alma mater | University of Sydney |
Thesis |
|
Academic work | |
Discipline |
|
Institutions | University of Otago |
Website | University of Otago profile |
Catherine Ann Malcolm Stedman is a New Zealand pharmacologist and gastroenterologist, and is a clinical professor at the University of Otago, specialising in hepatitis C drug development. She is the first woman gastroenterologist to become a professor of medicine in New Zealand.
Stedman completed her undergraduate medical degree at the University of Otago, and then undertook a PhD titled Role of nuclear receptors in bile acid disposition and detoxification at the University of Sydney in 2006. [1] Her clinical training in pharmacology and gastroenterology took place at Christchurch Hospital and Westmead Hospital in Sydney. [2] Stedman then worked in the Salk Institute, and on drug safety for a pharmaceutical company. [2] Stedman returned to Christchurch Hospital as a consultant gastroenterologist and joined the faculty of the University of Otago, rising to clinical associate professor in 2015 and full professor in 2023. [3] [4] She is the first woman gastroenterologist to become a professor of medicine in New Zealand. [2]
Stedman's research focuses on drug development for hepatitis C treatment, although she is also interested in autoimmune liver diseases, and how they affect the lives and life expectancy of people who have them. Stedman has been a principal investigator in a large number of clinical trials aimed at testing antiviral therapies, and led the first successful clinical trial in the world to show that oral antiviral treatment could cure hepatitis C. [4] Stedman has also led trials for antiviral therapies aimed at patients with liver failure resulting from hepatitis C. [4] As a result of these trials, and other potential therapies, the World Health Organization has proposed elimination of hepatitis C. [4] [5] [6] [7]
As of 2024, Stedman is the president of the New Zealand Society of Gastroenterology. [2]
In 2019 Stedman was awarded the Gold Research Medal by the University of Otago Christchurch campus. [8]
{{
cite journal}}
: CS1 maint: numeric names: authors list (
link){{
cite journal}}
: CS1 maint: numeric names: authors list (
link)